| Schedule of Computation of Net Loss Per Common Share |
The following table sets forth the computation of earnings (loss) per common share: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen weeks ended | | Twenty-six weeks ended | | (dollar amounts in thousands) | June 28,
2026 | | June 29,
2025 | | June 28,
2026 | | June 29,
2025 | Net income (loss) | $ | (26,270) | | | $ | (23,158) | | | $ | 99,539 | | | $ | (48,197) | | | | | | | | | | Weighted-average common shares outstanding—basic | 118,898,524 | | | 117,827,054 | | | 118,803,299 | | | 117,566,164 | | Dilutive stock awards | — | | | — | | | 1,971,381 | | | — | | Weighted-average common shares outstanding—diluted | 118,898,524 | | | 117,827,054 | | | 120,774,680 | | | 117,566,164 | | | | | | | | | | Earnings (loss) per share—basic | $ | (0.22) | | | $ | (0.20) | | | $ | 0.84 | | | $ | (0.41) | | Earnings (loss) per share—diluted | $ | (0.22) | | | $ | (0.20) | | | $ | 0.82 | | | $ | (0.41) | |
|
| Schedule of Anti-dilutive Shares Excluded |
| | | | | | | | | | | | | | | | | | | | | | | | | Thirteen weeks ended | | Twenty-six weeks ended | | June 28,
2026 | | June 29,
2025 | | June 28,
2026 | | June 29,
2025 | | Options to purchase common stock | 14,638,022 | | | 13,792,250 | | | 10,677,571 | | | 13,792,250 | | | | | | | | | | | Time-based vesting restricted stock units | 1,785,753 | | | 573,387 | | | 712,778 | | | 573,387 | | | Performance stock units | 4,900,000 | | | 4,500,000 | | | 4,500,000 | | | 4,500,000 | | | Contingently issuable stock | — | | | 250,000 | | | — | | | 250,000 | | | Total common stock equivalents | 21,323,775 | | | 19,115,637 | | | 15,890,349 | | | 19,115,637 | |
|